Kuala lumpur: Supermax Corporation Bhd's associate company, Supermax Brasil Importadora S/A (Supermax Brasil), is set to establish a medical glove manufacturing facility in the State of Paraná, Brazil, with an investment commitment of approximately 250 million Brazilian Real (US$50 million). According to BERNAMA News Agency, this strategic investment marks a significant milestone in Supermax's long-term international expansion strategy, underscoring the company's dedication to bolstering its presence in the Latin American healthcare and industrial markets. Brazil is seen as a promising growth opportunity due to its expanding healthcare sector, rising regional demand for medical and industrial gloves, strategic access to the Mercosur market, and government initiatives aimed at boosting local manufacturing and reducing import dependency. The project will involve developing an integrated manufacturing facility with installed production capacity, flexible manufacturing capabilities, and targeted market outreach . Supermax Brasil has been actively coordinating with Brazilian authorities and stakeholders to implement the project and foster a local manufacturing ecosystem. The company also plans to expand its market reach into Mercosur associate member countries, including Chile, Colombia, Ecuador, Guyana, Panama, Peru, and Suriname. The investment will be executed in two phases. Phase 1 will see an initial investment of about 150 million Brazilian Real (US$30 million), funded through internally generated funds and retained earnings. Phase 2 will focus on subsequent expansion to support future market growth and regional demand. Meanwhile, Supermax reported a higher net loss of RM41.14 million for the third quarter ended March 31, 2026, compared to RM23.81 million in the same quarter the previous year. Revenue decreased to RM126.76 million from RM203.67 million, primarily due to the strengthening of the ringgit against the US dollar and a lower average selling price. For the nine months ending March 31, 2026, the net loss widened to RM234.19 million from RM93.35 million in the previous year's corresponding period, while revenue fell to RM519.76 million from RM627.11 million. Despite these challenges, the group maintains a positive outlook, driven by robust healthcare demand and improved overseas market conditions, which provide a solid foundation for resilience and sustainable value creation. Supermax remains confident in its turnaround and expects to return to profitability in the second half of 2026.